Background
Our technology
We exploit the unique
properties of human serum albumin (HSA) with incorporated lycopene to sense and
characterize pathogenic microorganisms at clinically relevant concentrations with
a rapid (<20 minutes) test. We characterize the free radicals produced by pathogenic microorganisms, via their effect on serum albumin (in our proprietary reagent).
We
characterize this free radical production as a surrogate for pathogen metabolic activity. Our methods have a demonstrated ability of detecting over 30
different microorganisms (covering most reported cases of bloodstream infection),
with a demonstrated limit of detection below 10 CFU/mL. Our methods have also been shown (in multiple clinical studies) to be applicable to patient samples, and have a
good concordance with standard blood culture results.
Current status
Additional applications will be added in the future as warranted by additional development
Landscape
By contrast, our InSpector-01 tool, even when combined with existing pathogen characterization tools, will reduce that timeline to 5-10 hours (in time for the 2nd or 3rd antimicrobial dose).
And if combined with our InSpector-02 and InSpector-03 tools, then the pathogen characterization information will be available within 5 hours ~ in time for the 2nd antimicrobial dose.